Samsung Biologics makes $1.8 billion all-cash offer for Switzerland’s PolyPeptide Group

South Korea’s Samsung Biologics said on Monday that it had made an all-cash bid of 1.46 billion Swiss francs ($1.8 billion) for Switzerland’s PolyPeptide Group.

Leave a Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright, All Rights Reserved © UCWE Media